Manufacturing HIV Drug in Pakistan: Ferozsons Partners with US-Based Gilead
Ferozsons Laboratories Limited (Ferozsons), a Pakistani pharmaceutical company, has entered into a non-exclusive voluntary license agreement with Gilead Sciences Ireland UC, a US-based biopharmaceutical company, for the manufacture and sale
WHO: Long-acting Injectable Lenacapavir Proves Effective in HIV Prevention for Women
WHO is pleased with the effectiveness of long-acting lenacapavir as PrEP in preventing HIV acquisition among women. The PURPOSE 1 trial results confirmed the safety and efficacy of this injectable